共 45 条
[1]
Bang H., Tsiatis A.A., Median regression with censored cost data, Biometrics, 58, 3, pp. 643-649, (2002)
[2]
Black W.C., The CE plane: A graphic representation of cost-effectiveness, Medical Decision Making, 10, 3, pp. 212-214, (1990)
[3]
Bloomfield D.J., Krahn M.D., Neogi T., Panzarella T., Smith T.J., Warde P., Willan A.R., Ernst S., Moore M.J., Neville A., Tannock I.F., Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: Based on a Canadian randomized tial with palliative end points, Journal of Clinical Oncology, 16, 6, pp. 2272-2279, (1998)
[4]
Blumenschein K., Johannesson M., Yokoyama K.K., Freeman P.R., Hypothetical versus real willingness to pay in the health care sector: Results from a field experiment, Journal of Health Economics, 20, 3, pp. 441-457, (2001)
[5]
Briggs A., Economic evaluation and clinical trials: Size matters: The need for greater power in cost analyses poses an ethical dilemma, Br. Med. J., 321, pp. 1362-1363, (2000)
[6]
Brookmeyer R., Median survival time, Encyclopedia of Biostatistics, (2005)
[7]
Chaudhary M.A., Stearns S.C., Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial, Statistics in Medicine, 15, 13, pp. 1447-1458, (1996)
[8]
Dinh P., Zhou X.-H., Nonparametric statistical methods for cost-effectiveness analyses, Biometrics, 62, 2, pp. 576-588, (2006)
[9]
Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L., Methods for the Economic Evaluation of Health Care Programmes, (2005)
[10]
Duan N., Smearing estimate: A nonparametric retransformation method, JASA, 78, pp. 605-610, (1983)